Dexcom (Nasdaq:DXCM) announced today that, following the conclusion of the third quarter, it submitted G7 CGM to the FDA.

BD (NYSE:BDX) and Ypsomed today announced a strategic collaboration to advance self-injection solutions for high-viscosity ...

January AI today unveiled new advancements to its AI-driven metabolic health app that helps users monitor and take control of ...

Luna Diabetes announced that it launched its pivotal trial for Luna, the company's miniature automated insulin delivery ...

Know Labs (NYSE:KNW) announced today that it appointed a new chief science officer (CSO) and interim chief technology officer ...

ViCentra announced that it received CE mark approval for its Kaleido insulin pump under European Medical Device Regulation ...

SpyGlass Pharma released 18-month follow-up data highlighting the potential of its (IOL)-based drug delivery platform.

Ypsomed announced today that it opened a new production hall at its German site in Schwerin to increase auto-injector ...

Medtronic (NYSE: MDT) announced today that it received FDA investigational device exemption (IDE) for its Prevail drug-coated ...

New CEO Mike Alvarez. [Image courtesy of Glooko] Glooko announced today that it secured $100 million in a financing round and appointed Mike Alvarez as its new CEO. Russ Johannesson said on LinkedIn ...

The National Institutes of Health (NIH) launched a nationwide consortium to address the rise in youth diagnosed with type 2 diabetes. According to a press release, NIH expects that trend — which it ...

The SCS Microinjector. [Image from the Clearside Biomedical website] Clearside Biomedical (Nasdaq:CLSD) today announced that the ODYSSEY study of its drug-device combination achieved its primary and ...